The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADVANTAGE SOLUTIONS INC | COM CL A | 00791N102 | 10,982 | 2,890,000 | SH | SOLE | 2,890,000 | 0 | 0 | ||
AVEANNA HEALTHCARE HLDGS INC | COM | 05356F105 | 184,418 | 81,600,880 | SH | SOLE | 81,600,880 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 1,603,119 | 60,632,356 | SH | SOLE | 60,632,356 | 0 | 0 | ||
DIVERSEY HLDGS LTD | ORD SHS | G28923103 | 1,561,304 | 236,561,159 | SH | SOLE | 236,561,159 | 0 | 0 | ||
SURGERY PARTNERS INC | COM | 86881A100 | 1,418,948 | 49,064,576 | SH | SOLE | 49,064,576 | 0 | 0 |